| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 100.64× | 100.64× | 112.16× | 130.73× | 193.40× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 2.21× | 2.26× | 1.37× | 3.70× | 3.94× | ||
| 0.17× | 0.17× | 0.16× | 0.16× | 0.15× | ||
| 2.72× | 2.72× | 4.01× | 6.50× | 4.97× | ||
| 1.06× | 1.06× | 0.99× | 1.34× | 0.98× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 193.40 | 130.73 | 112.16 | 100.64 | 100.64 | |
| Working Capital Turnover | 3.94 | 3.70 | 1.37 | 2.26 | 2.21 | |
| Asset Turnover | 0.15 | 0.16 | 0.16 | 0.17 | 0.17 | |
| Cash Conversion (CFO/Net Income) | 4.97 | 6.50 | 4.01 | 2.72 | 2.72 | |
| CFO/EBITDA | 0.98 | 1.34 | 0.99 | 1.06 | 1.06 |